BR3 expression on peripheral blood B lymphocytes in GO patients was reduced (MFI was decreased from 6.26 ± 4.91 at baseline to 4.05 ± 1.58 at the end of therapy, P = 0.0083, Table 3). This evidence concerns the gene TNFRSF13C and geroderma osteodysplastica.